|
Market Cap (24-Jun) $14,130,238 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (16-Aug) 1,155 (0.00%) (595th) |
|
52w High $0.79 |
52w Low $0.105 |
P/E - |
EPS -0.08 |
AGN released this announcement to the ASX on 15 May 2023, 8:22. The announcement is marked as price sensitive, and is 6 page(s) in length and 428.16kb in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 595th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (16 August 2024).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| Final Phase1 Clinical Trial Report | 15 May 2023, 8:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 April 2023, 8:02 |
| Latest Preclinical HIE Study Results | 20 April 2023, 8:13 |
| Significant Non-Dilutive Funding For Preclinical HIE Studies | 30 March 2023, 9:28 |
You must be logged in to post a reply.
